🇺🇸 Antiplatelet Agents in United States
12 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 12
Most-reported reactions
- Chest Pain — 2 reports (16.67%)
- Dizziness — 2 reports (16.67%)
- Abdominal Distension — 1 report (8.33%)
- Acute Kidney Injury — 1 report (8.33%)
- Acute Left Ventricular Failure — 1 report (8.33%)
- Angina Pectoris — 1 report (8.33%)
- Asthenia — 1 report (8.33%)
- Balance Disorder — 1 report (8.33%)
- Bundle Branch Block Left — 1 report (8.33%)
- Cerebrovascular Accident — 1 report (8.33%)
Other Cardiovascular approved in United States
Frequently asked questions
Is Antiplatelet Agents approved in United States?
Antiplatelet Agents does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Antiplatelet Agents in United States?
Beijing Tiantan Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.